0001144204-14-002372.txt : 20140115
0001144204-14-002372.hdr.sgml : 20140115
20140115141813
ACCESSION NUMBER: 0001144204-14-002372
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20140115
DATE AS OF CHANGE: 20140115
EFFECTIVENESS DATE: 20140115
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: RedHill Biopharma Ltd.
CENTRAL INDEX KEY: 0001553846
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-210166
FILM NUMBER: 14529478
BUSINESS ADDRESS:
STREET 1: 21 HA'ARBA'A STREET
CITY: TEL AVIV
STATE: L3
ZIP: 64739
BUSINESS PHONE: 972-3-541-3131
MAIL ADDRESS:
STREET 1: 21 HA'ARBA'A STREET
CITY: TEL AVIV
STATE: L3
ZIP: 64739
D
1
primary_doc.xml
X0707
D
LIVE
0001553846
RedHill Biopharma Ltd.
21 HA'ARBA'A STREET
TEL AVIV
L3
ISRAEL
64739
972-3-5413131
ISRAEL
None
None
Corporation
true
2009
Ori
Shilo
21 Ha'arba'a Street
Tel Aviv
L3
ISRAEL
64739
Executive Officer
Director
Deputy Chief Executive Officer Finance and Operations and Director
Dror
Ben Asher
21 Ha'arba'a Street
Tel Aviv
L3
ISRAEL
64739
Executive Officer
Director
CEO and Chairman of the Board of Directors
Eric
Swenden
21 Ha'arba'a Street
Tel Aviv
L3
ISRAEL
64739
Director
Kenneth
Reed
21 Ha'arba'a Street
Tel Aviv
L3
ISRAEL
64739
Director
Dan
Suesskind
21 Ha'arba'a Street
Tel Aviv
L3
ISRAEL
64739
Director
Ofer
Tsimchi
21 Ha'arba'a Street
Tel Aviv
L3
ISRAEL
64739
Director
External Director
Aliza
Rotbard
21 Ha'arba'a Street
Tel Aviv
L3
ISRAEL
64739
Director
External Director
Reza
Fathi
21 Ha'arba'a Street
Tel Aviv
L3
ISRAEL
64739
Executive Officer
Senior Vice President Research and Development
Guy
Goldberg
21 Ha'arba'a Street
Tel Aviv
L3
ISRAEL
64739
Executive Officer
Chief Business Officer
Adi
Frish
21 Ha'arba'a Street
Tel Aviv
L3
ISRAEL
64739
Executive Officer
Senior Vice President Business Development and Licensing
Gilead
Raday
21 Ha'arba'a Street
Tel Aviv
L3
ISRAEL
64739
Executive Officer
Senior Vice President Research and Development
Uri
Hananel Aharon
21 Ha'arba'a Street
Tel Aviv
L3
ISRAEL
64739
Executive Officer
Chief Accounting Officer
Pharmaceuticals
$1 - $1,000,000
- 06b
false
2013-12-31
false
true
true
false
0
Roth Capital Partners, LLC
15407
None
None
730 FIFTH AVE., 25TH FLOOR
NEW YORK
NY
NEW YORK
10019
NY
NEW YORK
false
Stifel, Nicolaus & Company, Incorporated
793
None
None
787 7TH AVE., 11TH FLOOR
NEW YORK
NY
NEW YORK
10019
NY
NEW YORK
false
2500020
2500020
0
false
1
175000
true
0
Final amount being negotiated and not yet determined.
0
false
RedHill Biopharma Ltd.
/s/ Ori Shilo
Ori Shilo
Deputy CEO Finance and Operations and Director
2014-01-15